Page last updated: 2024-10-25

clioquinol and Fasting Hypoglycemia

clioquinol has been researched along with Fasting Hypoglycemia in 1 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Fasting Hypoglycemia: HYPOGLYCEMIA expressed in the postabsorptive state, after prolonged FASTING, or an overnight fast.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suh, SW1
Won, SJ1
Hamby, AM1
Yoo, BH1
Fan, Y1
Sheline, CT1
Tamano, H1
Takeda, A1
Liu, J1

Other Studies

1 other study available for clioquinol and Fasting Hypoglycemia

ArticleYear
Decreased brain zinc availability reduces hippocampal neurogenesis in mice and rats.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2009, Volume: 29, Issue:9

    Topics: Animals; Carrier Proteins; Cation Transport Proteins; Cell Proliferation; Chelating Agents; Clioquin

2009